Seppo Parkkila, PhD, Professor

Faculty of Medicine and Health Technology, University of Tampere, Finland, Finland

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1126 - Effect of Remdesivir on Recovery, Quality of Life, and Long-COVID Symptoms One Year after Hospitalization for COVID-19 Infection: A Randomized Controlled SOLIDARITY Finland Trial
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET